Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...

Medtronic's Reveal XT subcutaneous cardiac monitor is now commercially available in the U.S. The company introduced Reveal XT in Europe in July of 2007. The device helps physicians diagnose heart ...

After receiving the necessary regulatory approval, Medtronic is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance ...

The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...

GAITHERSBURG, Md., March 1 (Reuters) - A U.S. advisory panel on Thursday voted 9-2 against recommending approval of a Medtronic Inc. implantable device that monitors the heart and sends data to ...

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient’s chest during a minimally invasive procedure. The implanted device allows clinicians to continuously ...

Medtronic Plc (NYSE:MDT) has recalled certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) with glassed feedthrough. The FDA has ...

Parkview Health announced today that its Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to participate in a clinical trial of a new heart ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

On February 20, 2024, Medtronic MDT Corporation (NYSE: MDT, $85.90, Market Capitalization: $114.2 billion) in its 3Q24 earnings call announced that it no longer plans to spin-off its Patient ...